Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04689867 · ClinicalTrials.gov registry record · NA
Cognitive Behavioral Suicide Prevention for Psychosis: Aim 1
A NA study, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT04689867: Completed NA study, sponsored by University of Michigan.
NCT04689867 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 5 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04689867, a NA study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
The investigators are modifying and testing the preliminary effectiveness and implementation of a Cognitive Behavioral Suicide Prevention for psychosis (CBSPp) intervention. In this phase of the study, CBSPp will be tested in an initial open trial (n = 10) to examine its feasibility and acceptability. Investigators will recruit clients receiving services at a community mental health setting who have a schizophrenia spectrum disorder and recent suicidal thoughts and behaviors to receive the behavioral intervention for 10-weeks. Providers will be recruited and trained to deliver the intervention. Both clients and providers will be assessed at baseline to test our approach to measurement prior to the Aim 2 RCT (registered separately). Clients will be assessed at three additional timepoints (middle of treatment, end of treatment, and 2 months after treatment ends.
Primary Outcome
A scale to measure depression with scores ranging from 0 to 27 and greater scores indicating greater depression. Item 8 of the scale measures suicide thoughts and behaviors.
Interventions
- BEHAVIORAL Cognitive Behavioral Suicide Prevention for psychosis CBSPp)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2021-09-01 |
| Est. Completion | 2022-04-11 |
| Phase | NA |
What the finished NCT04689867 record still lists
NCT04689867 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Cognitive Behavioral Suicide Prevention for psychosis CBSPp) is the first listed.
NCT04689867 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04689867 about?
NCT04689867 is a clinical study titled "Cognitive Behavioral Suicide Prevention for Psychosis: Aim 1". The investigators are modifying and testing the preliminary effectiveness and implementation of a Cognitive Behavioral Suicide Prevention for psychosis (CBSPp) intervention. In this phase of the study, CBSPp will be tested in an initial open trial (n = 10) to examine its feasibility and acceptabilit...
What is the current status of trial NCT04689867?
This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2021-09-01. Estimated completion is 2022-04-11.
What interventions are being tested in trial NCT04689867?
The interventions under investigation include: Cognitive Behavioral Suicide Prevention for psychosis CBSPp) (BEHAVIORAL).
Who is sponsoring clinical trial NCT04689867?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04689867's enrollment target sits among peer trials
5 1988th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI